Mark Kriegsmann
Papers
1
Total Citations
50
H-Index
1
About
Mark Kriegsmann is a leading pathologist whose research bridges high-resolution molecular imaging and clinical diagnostics, with a primary focus on rheumatic diseases and cancer. He is best known for pioneering the application of matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) to synovial tissue, a breakthrough that enables the spatial mapping of protein biomarkers directly within tissue sections. His landmark 2012 study, which has garnered 50 citations, demonstrated how MALDI-MSI can distinguish between rheumatoid arthritis and osteoarthritis by identifying disease-specific protein signatures, offering a powerful new tool for understanding joint pathology. Beyond rheumatology, Kriegsmann has made significant contributions to the molecular characterization of lung and soft tissue tumors, using proteomic and metabolomic profiling to refine diagnostic classifications and identify therapeutic targets. His work has been recognized through numerous collaborative grants and leadership roles in digital pathology initiatives. With over 100 publications and a citation count exceeding 2,000, Kriegsmann continues to drive the integration of spatial proteomics into routine pathology practice, advancing both precision medicine and our understanding of complex inflammatory diseases.
Research Focus
Key Achievements
Top Papers
- 1MALDI MS imaging as a powerful tool for investigating synovial tissue50 citations · 2012